Carcinogenesis Advance Access published online on November 26, 2008
Carcinogenesis, doi:10.1093/carcin/bgn265
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Rottlerin induces apoptosis via death receptor5 (DR5) up-regulation through CHOP-dependent and PKC
-independent mechanism in human malignant tumor cells
1 Department of Immunology and Chronic Disease Research Center and Institute for Medical Science, School of Medicine, Keimyung University, 194 DongSan-Dong Jung-Gu, Taegu 700-712, South Korea
2 Institute for Medical Sciences, Ajou University School of Medicine, 5 Woncheon-Dong, Paldal-Gu, Suwon 442-749, South Korea
3 Department of Genetic Engineering, College of Natural Sciences, Kyungpook National University, Taegu, Korea
* Corresponding author Taeg Kyu Kwon, Department of Immunology, School of Medicine, Keimyung University, 194 DongSan-Dong, Jung-Gu, Taegu, 700-712, Korea. Tel.: 82-53-250-7846, Fax: 82-53-250-7074. e-mail: kwontk{at}dsmc.or.kr
Rottlerin has been shown to induce anti-proliferation and apoptosis of human cancer cell lines. In this study, we demonstrate a novel mechanism of rottlerin-induced apoptosis via death receptor 5 (DR5) up-regulation. We found that treatment with rottlerin significantly induces DR5 expression both at its mRNA and protein levels. Down-regulation of DR5 expression with siRNA efficiently attenuated rottlerin-induced apoptosis, showing that the critical role of DR5 in this cell death. Rottlerin-induced DR5 up-regulation was accompanied by CCAAT/enhancer-binding protein-homologous protein (CHOP) protein expression and rottlerin-induced increase of DR5 promoter activity was diminished by mutation of a CHOP-binding site of DR5 promoter. Although rottlerin is known to be as an inhibitor of novel isoforms of protein kinase C (PKC), specifically PKC
, not only suppression of PKC
expression by siRNA but also overexpression of WT-PKC
or DN-PKC
did not affect the rottlerin-mediated induction of DR5 in our study. These results suggest that rottlerin induces up-regulation of DR5 via PKC
-independent pathway. Furthermore, subtoxic dose of rottlerin sensitizes human cancer cells, but not normal cells, to TRAIL-mediated apoptosis. Thus, DR5-mediated apoptosis, which is induced by rottlerin alone or by the combined treatment with rottlerin and TRAIL, may offer a new therapeutic strategy against cancer.
Key Words: Rottlerin DR5 Apoptosis PKC
CHOP
Received June 25, 2008; revised October 23, 2008; accepted November 20, 2008.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
T. W. Day, C.-H. Wu, and A. R. Safa Etoposide Induces Protein Kinase C{delta}- and Caspase-3-Dependent Apoptosis in Neuroblastoma Cancer Cells Mol. Pharmacol., September 1, 2009; 76(3): 632 - 640. [Abstract] [Full Text] [PDF] |
||||
